Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AVNR > SEC Filings for AVNR > Form 8-K on 5-May-2014All Recent SEC Filings

Show all filings for AVANIR PHARMACEUTICALS, INC.

Form 8-K for AVANIR PHARMACEUTICALS, INC.


5-May-2014

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On April 30, 2014, Avanir Pharmaceuticals, Inc. (the "Company") issued a press release announcing that the U.S. District Court for the District of Delaware ruled in favor of the Company in the Company's patent infringement lawsuit against Par Pharmaceuticals, Inc. and Impax Laboratories, Inc. in conjunction with their Abbreviated New Drug Applications for generic versions of NUEDEXTAŽ capsules for the treatment of pseudobulbar affect (the "Press Release"). The decision provides market exclusivity for NUEDEXTA through 2026. A copy of the Press Release is filed herewith as Exhibit 99.1 and is incorporated by reference herein.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

99.1 Press Release, dated April 30, 2014

* * *


  Add AVNR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AVNR - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.